Peritoneal Dialysis Device Market: Current Analysis and Forecast (2023-2030)

Peritoneal dialysis (PD) is a type of dialysis treatment that uses the lining of the abdomen, called the peritoneum, as a natural filter to clean the blood. PD is a form of home dialysis, which means that you can perform the treatment at home, rather than having it done in a dialysis center. The peritoneal dialysis (PD) device market is a growing industry that provides devices and supplies for the treatment of end-stage renal disease (ESRD) through peritoneal dialysis. The market includes a range of products, including PD machines, dialysis solutions, and accessories. The PD device market is driven by several factors, including the increasing prevalence of ESRD, the aging population, and the growing demand for home dialysis. PD is a preferred treatment option for many patients due to its flexibility and convenience, and as a result, the market for PD devices is expected to continue to grow in the coming years..

The Peritoneal Dialysis Device Market is expected to grow at a steady rate of around 7% owing to the increasing demand for driver safety and advancements in wearable technology. With the increasing number of accidents on the road, there is a growing demand for technologies that can help improve driver safety. Peritoneal Dialysis Device could be a valuable tool for reducing the risk of accidents and improving overall driving performance.

Based on product type, the market is segmented into cyclers, fluids, and others. The cyclers category is to witness a higher CAGR during the forecast period. In Cyclers are machines that are used to perform continuous cycling peritoneal dialysis (CCPD), which is a type of PD that involves cycling the dialysis solution in and out of the peritoneal cavity using a machine.

Based on the end-users, the market has been classified into hospitals, ambulatory surgical centers, and clinics. The hospitals category held a dominating share in 2022. The hospitals segment is expected to continue to be a significant player in the PD device market, driven by the increasing demand for PD treatment. PD is a preferred treatment option for many patients due to its flexibility and convenience, and as a result, the demand for PD treatments in hospitals is expected to continue to grow in the forecast years.

For a better understanding of the market adoption of the peritoneal dialysis device industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. The North American PD device market is driven by a number of factors, including the increasing prevalence of ESRD, the aging population, and the growing demand for home dialysis. PD is a preferred treatment option for many patients due to its flexibility and convenience, and as a result, the market for PD devices in North America is expected to continue to grow in the coming years.

Some of the major players operating in the market include: Fresenius Medical Care; Baxter International; Nipro Corporation; JMS Co. Ltd.; Nikkiso Co., Ltd.; Nihon Kohden Corporation; Dopamine Infusion Systems (a subsidiary of Hospira, now part of Pfizer); Smiths Medical; Janssen Pharmaceuticals (a subsidiary of Johnson & Johnson); and Terumo Corporation.